-

Trinity Life Sciences Launches Quick Payer Pulse, Allowing Clients to Validate Pricing and Access Assumptions in Days

Upcoming Webinar “Business Development: Getting Pricing & Access Inputs Right” Tackles the Most Common High-Impact Challenges Inherent in Business Development

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces Quick Payer Pulse—a proprietary survey tool that generates and quantifies country-specific payer insights to support time-sensitive business needs. In life sciences, pricing and access are vital to an asset’s success globally. As assets go through earlier development phases or M&A processes, there are many situations where a payer pulse-check is needed to make efficient, informed decisions.

Quick Payer Pulse enables rapid, informed business decisions by leveraging Trinity’s in-depth knowledge of the global payer landscape—and access to payer stakeholders—to provide a snapshot of payer perceptions within days.

Life sciences leaders leverage Quick Payer Pulse to gain:

  • Fast, accurate payer input from key payer experts across the U.S., the U.K., Germany, France, Italy, Spain and Canada
  • Instant access to Trinity’s global payer panel through geographically tailored questions to capture an expert-built snapshot of payer opinion
  • Unique time efficiencies—surveys are built-for-purpose with Trinity’s expertise and in-house technology, taking the survey creation burden away from clients (still allowing for optional custom questions)
  • Flexible purchasing options, including a credits-based subscription to support continual needs for fast assessments (target product profile refinements, de-risking initial price points, external validation, etc.) by streamlining logistics like contracting paperwork and compliance review
  • And much more

“Given the rapidly evolving pricing and access landscape, payer feedback is often an essential decision input for life science executives,” explained Monica Martin De Bustamante, Senior Partner & Head of Evidence, Value, Access & Pricing at Trinity Life Sciences. “When fast input is part of the business need, time itself becomes the key challenge - we created Quick Payer Pulse to ensure access to high-speed payer feedback shaped by Trinity's deep expertise.”

A webinar, “Business Development: Getting Pricing & Access Inputs Right,” on November 30 will discuss the vital need to make rapid, informed decisions on pricing and market access assumptions for Business Development forecasting models—as well as best practice approaches to pricing and market access inputs into the Business Development process. Life science executives can register here.

Members of the media who would like to attend can contact Elizabeth Marshall at emarshall@trinitylifesciences.com.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Media Contact:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Media Contact:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom